CDK4 regulation by TNFR1 and JNK is required for NF-κB–mediated epidermal growth control

JY Zhang, S Tao, R Kimmel, PA Khavari - The Journal of cell biology, 2005 - rupress.org
JY Zhang, S Tao, R Kimmel, PA Khavari
The Journal of cell biology, 2005rupress.org
Nuclear factor κB (NF-κB) mediates homeostatic growth inhibition in the epidermis, and a
loss of NF-κB function promotes proliferation and oncogenesis. To identify mechanisms
responsible for these effects, we impaired NF-κB action in the epidermis by three different
genetic approaches, including conditional NF-κB blockade. In each case, epidermal
hyperplasia was accompanied by an increase in both protein levels and tissue distribution of
the G1 cell cycle kinase, CDK4. CDK4 up-regulation required intact TNFR1 and c-Jun NH2 …
Nuclear factor κB (NF-κB) mediates homeostatic growth inhibition in the epidermis, and a loss of NF-κB function promotes proliferation and oncogenesis. To identify mechanisms responsible for these effects, we impaired NF-κB action in the epidermis by three different genetic approaches, including conditional NF-κB blockade. In each case, epidermal hyperplasia was accompanied by an increase in both protein levels and tissue distribution of the G1 cell cycle kinase, CDK4. CDK4 up-regulation required intact TNFR1 and c-Jun NH2-terminal kinase (JNK) function. Cdk4 gene deletion concomitant with conditional NF-κB blockade demonstrated that CDK4 is required for growth deregulation. Therefore, epidermal homeostasis depends on antagonist regulation of CDK4 expression by NF-κB and TNFR1/JNK.
rupress.org